Thalomid and Incontinence - a phase IV clinical study of FDA data

Summary:

Incontinence is reported as a side effect among people who take Thalomid (thalidomide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Autoimmune disorder.

The phase IV clinical study analyzes which people have Incontinence when taking Thalomid. It is created by eHealthMe based on reports of 38,055 people who have side effects when taking Thalomid from the FDA, and is updated regularly.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.

What is Incontinence?

Incontinence (lack of moderation or self-control) is found to be associated with 954 drugs and 1,123 conditions by eHealthMe. Check the latest studies of Incontinence.

On Jul, 26, 2026

38,055 people reported to have side effects when taking Thalomid.
Among them, 28 people (0.07%) have Incontinence.

Among these 28 people:

How long have people been on Thalomid when they have Incontinence? *

What is the gender of people who have Incontinence when taking Thalomid? *

female: 29.63 %
male: 70.37 %

What is the age of people who have Incontinence when taking Thalomid? *

What are other drugs people take besides Thalomid? *

What are other side effects people have besides Incontinence? *

Weakness: 8 people, 28.57%
Fever: 8 people, 28.57%
Hypotension (abnormally low blood pressure): 6 people, 21.43%
Pleural Effusion (water on the lungs): 4 people, 14.29%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 4 people, 14.29%
Diarrhea: 4 people, 14.29%
Fatigue (feeling of tiredness): 4 people, 14.29%
Haemoglobin Decreased: 4 people, 14.29%
Dyspnea (difficult or laboured breathing): 4 people, 14.29%
Confusional State: 4 people, 14.29%

What are the existing conditions these people have? *

Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 2 people, 7.14%
Prostate Cancer: 1 person, 3.57%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 3.57%
Castleman's Disease (a disease of lymph nodes and related tissues): 1 person, 3.57%
Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Thalomid and have Incontinence?

- Check whether Incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalomid:

Thalomid (38,099 reports)

Incontinence treatments and more:

Incontinence (18,003 reports)

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Incontinence:

Incontinence (954 drugs)

Browse all the conditions that are associated with Incontinence:

Incontinence (1,123 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalomid) and Thalomid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.